Genetic testing for the BRAF V600E mutation may also be done for the specimen, as it is found in 70.49% of ameloblastoma cases with a significant association for patients aged less than 54 years old and in cases with mandibular origin [23], although it, unfortunately, won’t be able to predict the patient's prognosis [24]. The gene discussed is BRAF; the disease is ameloblastoma.